Diligence memo · auto-generated · as of July 2, 2026
General Fluidics Corp
General Fluidics Corp looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
General Fluidics Corp operates in Other Health Care, based in WALTHAM.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
General Fluidics Corp has raised $35M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $18M on 2024-07-16.
Most recent recorded round closed around 2024-07-16.
Valuation (modeled)modeled
Provath models General Fluidics Corp at approximately $119M (range $43M–$212M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.78× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era. Within the normal band (78% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 17 months.
Last raise 24 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 4.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 90% of Other Health Care peers (5377 compared).
Modeled value ranks above 82% of those peers.
Closest niche peers: Code Biotherapeutics, Inc., Candesant Biomedical, Inc., Artis Holdings, LLC, GIO Blood Ltd, Clarapath, Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.